• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3D生物打印在治疗新冠肺炎心肌损伤患者方面优于心脏细胞治疗和传统组织工程的前景。

Prospect of 3D bioprinting over cardiac cell therapy and conventional tissue engineering in the treatment of COVID-19 patients with myocardial injury.

作者信息

Akter Fariya, Araf Yusha, Naser Iftekhar Bin, Promon Salman Khan

机构信息

Biotechnology Program, Department of Mathematics and Natural Sciences, Brac University, Dhaka, Bangladesh.

Department of Genetic Engineering and Biotechnology, School of Life Sciences, Shahjalal University of Science and Technology, Sylhet, Bangladesh.

出版信息

Regen Ther. 2021 Dec;18:447-456. doi: 10.1016/j.reth.2021.09.007. Epub 2021 Sep 30.

DOI:10.1016/j.reth.2021.09.007
PMID:34608441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8481096/
Abstract

Due to multiple mutations of SARS-CoV-2, the mystery of defeating the virus is still unknown. Cardiovascular complications are one of the most concerning effects of COVID-19 recently, originating from direct and indirect mechanisms. These complications are associated with long-term Cardio-vascular diseases and can induce sudden cardiac death in both infected and recovered COVID-19 patients. The purpose of this research is to do a competitive analysis between conventional techniques with the upgraded alternative 3D bioprinting to replace the damaged portion of the myocardium. Additionally, this study focuses on the potential of 3D bioprinting to be a novel alternative. Finally, current challenges and future perspective of 3D bioprinting technique is briefly discussed.

摘要

由于新冠病毒的多种突变,战胜该病毒的奥秘仍不为人知。心血管并发症是近期新冠肺炎最令人担忧的影响之一,其源于直接和间接机制。这些并发症与长期心血管疾病相关,可导致新冠肺炎感染患者和康复患者的心源性猝死。本研究的目的是对传统技术与升级后的替代技术3D生物打印进行对比分析,以替代受损的心肌部分。此外,本研究聚焦于3D生物打印成为一种新型替代方案的潜力。最后,简要讨论了3D生物打印技术当前面临的挑战和未来前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8551545/2f64b9803169/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8551545/b98144823d00/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8551545/2f64b9803169/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8551545/b98144823d00/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8551545/2f64b9803169/gr2.jpg

相似文献

1
Prospect of 3D bioprinting over cardiac cell therapy and conventional tissue engineering in the treatment of COVID-19 patients with myocardial injury.3D生物打印在治疗新冠肺炎心肌损伤患者方面优于心脏细胞治疗和传统组织工程的前景。
Regen Ther. 2021 Dec;18:447-456. doi: 10.1016/j.reth.2021.09.007. Epub 2021 Sep 30.
2
3D bioprinting in cardiac tissue engineering.三维生物打印在心脏组织工程中的应用。
Theranostics. 2021 Jul 6;11(16):7948-7969. doi: 10.7150/thno.61621. eCollection 2021.
3
3D bioprinted functional and contractile cardiac tissue constructs.3D 生物打印的功能性和收缩性心脏组织构建体。
Acta Biomater. 2018 Apr 1;70:48-56. doi: 10.1016/j.actbio.2018.02.007. Epub 2018 Feb 13.
4
Applications of 3D Bioprinting in Tissue Engineering and Regenerative Medicine.3D生物打印在组织工程和再生医学中的应用。
J Clin Med. 2021 Oct 26;10(21):4966. doi: 10.3390/jcm10214966.
5
3D bioprinting of cardiac tissue: current challenges and perspectives.三维生物打印心脏组织:当前的挑战与展望。
J Mater Sci Mater Med. 2021 May 6;32(5):54. doi: 10.1007/s10856-021-06520-y.
6
Biomaterial-based 3D bioprinting strategy for orthopedic tissue engineering.用于骨科组织工程的基于生物材料的3D生物打印策略
Acta Biomater. 2023 Jan 15;156:4-20. doi: 10.1016/j.actbio.2022.08.004. Epub 2022 Aug 10.
7
Trends in 3D bioprinting for esophageal tissue repair and reconstruction.三维生物打印在食管组织修复和重建中的研究进展。
Biomaterials. 2021 Jan;267:120465. doi: 10.1016/j.biomaterials.2020.120465. Epub 2020 Oct 19.
8
Advances in three-dimensional bioprinted stem cell-based tissue engineering for cardiovascular regeneration.三维生物打印干细胞组织工程在心血管再生中的研究进展。
J Mol Cell Cardiol. 2022 Aug;169:13-27. doi: 10.1016/j.yjmcc.2022.04.017. Epub 2022 May 12.
9
3D bioprinting of emulating homeostasis regulation for regenerative medicine applications.三维生物打印模拟体内平衡调控在再生医学中的应用。
J Control Release. 2023 Jan;353:147-165. doi: 10.1016/j.jconrel.2022.11.035. Epub 2022 Nov 24.
10
3D printing approaches for cardiac tissue engineering and role of immune modulation in tissue regeneration.3D 打印技术在心脏组织工程中的应用及免疫调节在组织再生中的作用。
Int J Nanomedicine. 2019 Feb 20;14:1311-1333. doi: 10.2147/IJN.S189587. eCollection 2019.

引用本文的文献

1
In vitro high-content tissue models to address precision medicine challenges.用于解决精准医学挑战的体外高通量组织模型。
Mol Aspects Med. 2023 Jun;91:101108. doi: 10.1016/j.mam.2022.101108. Epub 2022 Aug 17.
2
Nanosponges: An overlooked promising strategy to combat SARS-CoV-2.纳米海绵:一种被忽视的有前途的对抗 SARS-CoV-2 的策略。
Drug Discov Today. 2022 Oct;27(10):103330. doi: 10.1016/j.drudis.2022.07.015. Epub 2022 Jul 28.

本文引用的文献

1
Current Advances in 3D Bioprinting Technology and Its Applications for Tissue Engineering.3D生物打印技术的当前进展及其在组织工程中的应用
Polymers (Basel). 2020 Dec 11;12(12):2958. doi: 10.3390/polym12122958.
2
Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration.用于心脏组织工程与再生的3D生物打印技术进展。
Bioact Mater. 2020 Nov 10;6(5):1388-1401. doi: 10.1016/j.bioactmat.2020.10.021. eCollection 2021 May.
3
Ventricular Arrhythmia Risk Based on Ethnicity in COVID-19 Patients on Hydroxychloroquine and Azithromycin Combination: Viewpoint.
基于种族的新冠肺炎患者联用羟氯喹和阿奇霉素时的室性心律失常风险:观点
SN Compr Clin Med. 2020;2(8):1019-1024. doi: 10.1007/s42399-020-00370-5. Epub 2020 Jun 27.
4
Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19).COVID-19 患者近期康复后的心血管磁共振成像结果。
JAMA Cardiol. 2020 Nov 1;5(11):1265-1273. doi: 10.1001/jamacardio.2020.3557.
5
Heart failure and COVID-19.心力衰竭与 COVID-19。
Heart Fail Rev. 2021 Jan;26(1):1-10. doi: 10.1007/s10741-020-10008-2.
6
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.新型冠状病毒肺炎与心血管疾病:从基础机制到临床展望。
Nat Rev Cardiol. 2020 Sep;17(9):543-558. doi: 10.1038/s41569-020-0413-9. Epub 2020 Jul 20.
7
In the eye of the storm: the right ventricle in COVID-19.风暴之眼:新型冠状病毒肺炎中的右心室
Pulm Circ. 2020 Jul 2;10(3):2045894020936660. doi: 10.1177/2045894020936660. eCollection 2020 Jul-Sep.
8
SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)、血管紧张素转换酶2(ACE2)与羟氯喹:当前环境下的心血管并发症、治疗方法及临床结果
Pathogens. 2020 Jul 7;9(7):546. doi: 10.3390/pathogens9070546.
9
COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors.COVID-19 相关心脏损伤:对幸存者长期监测和结局的影响。
Heart Rhythm. 2020 Nov;17(11):1984-1990. doi: 10.1016/j.hrthm.2020.06.026. Epub 2020 Jun 26.
10
COVID-19 Pandemic: Cardiovascular Complications and Future Implications.新型冠状病毒肺炎(COVID-19)大流行:心血管并发症及未来影响。
Am J Cardiovasc Drugs. 2020 Aug;20(4):311-324. doi: 10.1007/s40256-020-00420-2.